top of page

Speakers

Exciting progress is underway regarding surgical options for the breast and axilla in neoadjuvant chemotherapy patients, lymphedema prevention. How COVID-19 has impacted screening delays and the

effects of the vaccine on treatment. The evolution of the role of genomic profiling and genetic testing. Physicians involved with the diagnosis and management of breast cancer patients need to be kept apprised of new information in all of these areas.

Henry Ford Breast Cancer Program

Dunya Atisha, MD

Senior Medical Oncologist

Henry Ford Health

Division of Hematology Oncology

Chandler Cortina, MD, MS, FSSO, FAC

Radiation Oncologist

Henry Ford Cancer Institute

Vrushali Dabak MD.jpg

Vrushali Dabak, MD

Cancer Research, Cardiac Rehabilitation, Preventive Cardiology

Henry Ford Health

Laura Favazza.jpg

Laura Favazza, DO

Medical Director, Cancer Pain

Henry Ford Cancer Institute

Tasha Hughes, MD

Breast Oncology Surgeon Henry Ford Cancer Institute

Anna Lehrberg, DO

Breast Oncology Surgeon Henry Ford Cancer Institute

Provider Default Image.jpg

Obstetrics and Gynecology Surgeon Specializing in Women at High Risk for Breast Cancer

Henry Ford Cancer Institute

Madeline Stamper, LMSW, CCM

Breast Surgical Oncologist

Senior Staff Surgeon

Henry Ford Cancer Institute

Chairman for 5th Annual Breast Oncology Symposium

Eleanor Walker MD.jpg

Eleanor Walker, MD

Medical Oncology

Henry Ford Health

Washburn, Travis 2015.jpg

Travis Washburn, MS, CGC

Director Western Region Breast and Fairview Hospital Breast Programs, Director Breast Surgical Oncology Fellowship

Moll Cancer Center at Fairview Hospital

bottom of page